Our website will soon be relaunched with a fresh look and improved user experience. Take a look by visiting our test site.
Call us 24/7 at (888) 552-6760
Cancer Treatment Centers of America


Clinical Trials

Cancer Treatment Centers of America® (CTCA) offers clinical trials as part of our commitment to bringing our patients new and innovative cancer treatment options, especially for patients with advanced cancer or who may have run out of standard-of-care approaches. The research team at CTCA® carefully identifies and studies new and emerging treatment options that are supported by scientific and investigational research. Our goal is to find those with the strongest likelihood of positively impacting our patients, so we are better able to offer new treatments options. 

Clinical Trial

What is a clinical trial?

clinical trials

Click here for an at-a-glance look at a clinical trial

In the world of cancer research, clinical trials study the safety and effectiveness of new approaches to treating cancer, either with entirely new drugs or technologies or by using existing treatments in new ways. New treatments often take years of study before they win government approval. While the trials take their course, they often offer participating patients new options that may otherwise be unavailable to them, especially after exhausting conventional treatments. Our research team decides to participate as a clinical trial site only after careful consideration of the relative benefit to our patients.

Clinical trials are an essential testing ground for studying drugs and other treatments before they can be granted government approval. Generally speaking, researchers study whether the treatments:

  • Are effective in treating cancer
  • Work better than existing therapies used to treat a particular cancer
  • Are safe for patients
  • Cause serious side effects

Some of these trials may study new chemotherapy drugs, surgical approaches or radiation technologies. Others may explore whether a new or existing treatment works better in combination with others. One of the most exciting areas of cancer research focuses on precision treatment options. The new generation of precision drugs is generally designed to deliver more targeted, less toxic therapies. Typically, today’s precision-focused trials study new drugs that are not yet on the market, or new uses for existing drugs—to determine whether they can be used to treat additional cancer types, for example.

Qualifying

Do I qualify?

Because every clinical trial is different, the criteria for selecting qualified patients vary from trial to trial. Trial qualifications may require that you have a particular type or subtype of cancer or a specific genomic mutation, or that you are of a particular age range or that your cancer has progressed to an advanced stage. Many trials enroll participants who have exhausted conventional treatment options or who are no longer responding to those treatments. Not every patient is a candidate for available clinical trials. Your CTCA care team will work with you to determine if you qualify for an existing trial and, if so, will help you enroll.